Albumin–bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia

Figure 1 Platelet count in hepatocellular carcinoma patients stratified according to Child–Pugh, albumin–bilirubin and platelet–albumin–bilirubin grades. A: Stratified according to Child–Pugh; B: Stratified according to albumin–bilirubin; C: Stratified according to platelet–albumin–bilirubin. ALBI: Albumin–bilirubin; PALBI: Platelet–albumin–bilirubin; CP: Child–Pugh; PLT: Platelet count.

Figure 2 Kaplan–Meier cumulative overall survival and recurrence-free survival curves of the included population. A: Kaplan–Meier cumulative overall survival curve; B: Kaplan–Meier cumulative recurrence-free survival curve.

Figure 3 Kaplan–Meier cumulative overall survival and recurrence-free survival curves of the included patients stratified according to Child–Pugh, albumin–bilirubin and platelet–albumin–bilirubin. A: Overall survival (OS) curves stratified according to Child–Pugh (CP) classification; B: Recurrence-free survival (RFS) curves stratified according to CP; C: OS curves stratified according to albumin–bilirubin (ALBI); D: RFS curves stratified according to ALBI; E: OS curves stratified according to Platelet ALBI; F: RFS curves stratified according to PALBI. OS: Overall survival; RFS: Recurrence-free survival; CP: Child–Pugh; ALBI: Albumin–bilirubin; PALBI: Platelet–albumin–bilirubin.

Figure 4 Forest plots based the multivariate analyses results for overall survival and recurrence-free survival. A: Forest plot for overall survival; B: Forest plot for recurrence-free survival. HR: Hazard ratio; AFP: α-fetoprotein; RFS: Recurrence-free survival; OS: Overall survival.